350 jobs cut after rapid expansion: What is changing inside Even Healthcare?

Bengaluru-based Even Healthcare has reportedly eliminated around 350 jobs, equivalent to approximately 30% to 35% of its workforce, as the healthtech startup restructures operations around a more hospital-led healthcare model. The scale makes the retrenchment particularly notable because it is unfolding alongside fresh fundraising rather than following an obvious financing drought, underscoring how Even Healthcare is simultaneously reducing its cost base and directing capital toward the more infrastructure-intensive business of operating hospitals.

According to exclusive reporting by Kunal Manchanada at Entrackr, citing four people familiar with the matter, the job reductions have affected multiple teams as Even Healthcare phases down parts of its insurance business and shifts resources toward hospital operations. Moneycontrol subsequently reported a range of around 350 to 400 affected employees, representing roughly 30% to 35% of the workforce, and said the restructuring is connected to decisions over where resources should be deployed as hospital expansion becomes a higher priority. Even Healthcare had not publicly confirmed the layoff figures at the time of the reports and did not immediately respond to queries cited by Moneycontrol and Inc42.

The timing creates an important strategic tension. Just a day before the workforce reports emerged, regulatory-filing-based reporting showed that Even Healthcare’s board had approved a ₹208.24 crore Series B fundraising, equivalent to roughly $22 million, led by existing investor Khosla Ventures. The company is therefore not simply cutting costs because new financing has disappeared; it appears to be reshaping where both investor money and employee capacity are deployed as its business moves deeper into direct healthcare delivery.

Why is Even Healthcare reportedly cutting 30–35% of its workforce?

The reported Even Healthcare layoffs appear to be part of a wider restructuring rather than an isolated cost-cutting exercise. Entrackr reported that the company is reducing its cost base while reallocating resources toward its hospital-led model, and Moneycontrol separately cited people familiar with the business as saying hospital expansion has forced decisions about where capital and personnel should be concentrated. That distinction matters because Even Healthcare has evolved substantially from the subscription-led healthcare and insurance proposition on which much of its earlier growth was built.

Even Healthcare’s existing model connects primary care, diagnostic services, hospitalisation and post-discharge recovery. Its corporate offering has historically combined healthcare access with insurance-related benefits, while the company has increasingly moved closer to directly providing the medical services for which members previously relied on external hospital networks. The launch of its own multispeciality hospital in Bengaluru represented a major step in that transition.

Operating hospitals changes the economics of the company. A digital or membership-led health platform can expand customer reach without replicating every element of physical infrastructure, whereas hospital growth requires medical equipment, clinical staff, facilities, regulatory compliance and substantial working capital. Even Healthcare’s restructuring therefore appears to involve more than shrinking payroll: it is shifting resources from portions of the organisation associated with the earlier model toward an operating structure capable of supporting direct healthcare delivery.

The reported 30% to 35% reduction is nevertheless large enough to raise questions about how aggressively that transition is being executed. A company can simultaneously be expanding one part of its business and reducing another, but cuts approaching one-third of employees imply a substantial reconfiguration of responsibilities rather than ordinary annual workforce optimisation.

Why do the Even Healthcare layoffs matter more because fresh funding is arriving?

The financing picture makes the workforce restructuring unusually revealing. Regulatory filings cited by Entrackr showed that Even Healthcare’s board approved the issue of 191,228 compulsorily convertible preference shares at ₹10,889.91 each to raise ₹208.24 crore. Khosla Ventures is expected to contribute ₹145 crore, while DLB Ventures is investing ₹38.88 crore and Simon Fiduciaria ₹22.67 crore, with smaller contributions from ADBEEV LLP and Better Capital.

Entrackr estimated that the transaction values Even Healthcare at approximately $300 million. Earlier reporting from Mint and The Economic Times had indicated that the company was discussing a potentially larger $50 million equity raise at a similar valuation, although the filing-backed ₹208.24 crore transaction represents the clearer committed amount disclosed through the board resolution.

The company had already raised $20 million in January 2026 from investors including Lachy Groom and Alpha Wave Global. Consequently, Even Healthcare has been able to access fresh capital repeatedly while many privately held startups remain focused on extending runway and postponing expensive expansion projects.

Layoffs occurring alongside fresh financing therefore should not automatically be interpreted as evidence of an imminent funding crisis. A more plausible reading from the available disclosures is that investors are continuing to finance Even Healthcare’s growth strategy while management is simultaneously attempting to prevent the organisational cost base inherited from its earlier model from expanding alongside the hospital network.

That creates a sharper question for employees and investors alike: how much of the capital being raised is intended to finance incremental growth, and how much must effectively compensate for losses generated while the business transitions toward a potentially more capital-intensive model?

What do Even Healthcare’s losses reveal about the pressure behind the restructuring?

Even Healthcare’s recent financial trajectory helps explain why cost control remains important despite rapid revenue expansion. Filing-based figures reported by Entrackr showed FY25 operating revenue rising more than fourfold to approximately ₹25.43 crore from ₹6.24 crore in FY24. However, the company’s loss increased around 24.5% to ₹90.15 crore from ₹72.40 crore.

Those figures create a striking relationship between scale and losses. Even Healthcare generated roughly ₹25 crore of operating revenue in FY25 while recording losses of around ₹90 crore, meaning its absolute loss was more than three times operating revenue for that period. The comparison does not by itself measure cash burn because accounting losses can include non-cash and timing effects, but it illustrates why management may consider significant expense restructuring necessary even while investors remain willing to fund expansion.

Rapid revenue growth also needs to be viewed against the relatively small starting base. Increasing revenue fourfold is impressive in percentage terms, but the more important question for the next phase is whether each additional hospital and member cohort can move the company closer to sustainable unit economics rather than simply multiplying both revenue and operating expenses.

Even Healthcare has offered some encouraging evidence from its hospital strategy. The company has previously said its first Bengaluru hospital achieved operating break-even in less than six months, while Moneycontrol reported that management disclosed metrics including more than 350 surgeries, zero unplanned 30-day readmissions among the reported cohort and average lengths of stay at least 40% shorter than comparable procedures in typical settings. Those are company-reported operating indicators rather than independently audited evidence of the economics of a wider hospital network, but they help explain why management appears willing to concentrate additional capital behind the model.

Is Even Healthcare abandoning insurance or changing how insurance fits its model?

The restructuring should not necessarily be read as Even Healthcare abandoning every insurance-related activity. Its existing proposition has combined medical access, healthcare management and optional insurance benefits, while reporting around the layoffs indicates that parts of the insurance business are being phased down as resources move toward direct healthcare delivery.

The strategic logic is potentially significant. Traditional health insurance economics are heavily influenced by claims costs and the behaviour of external healthcare providers. A vertically integrated model gives Even Healthcare greater involvement in the entire patient journey, from primary consultations and diagnostics through hospitalisation and monitored recovery. In theory, better coordination could reduce unnecessary admissions, shorten hospital stays and lower readmission rates while creating a more predictable healthcare cost structure.

The trade-off is capital intensity. Greater control over medical delivery requires greater responsibility for hospital operations, staffing and infrastructure. Even Healthcare is therefore moving from a model where technology and healthcare financing play prominent roles toward one in which physical clinical operations increasingly influence financial performance.

That makes the workforce reduction easier to understand strategically, even if it does not lessen the effect on employees. Teams built for one operating architecture may not map neatly onto another, particularly when management is simultaneously trying to lower overhead and redirect capital toward facilities and clinical capacity.

How unusual is a 350-job reduction for a rapidly growing Indian healthtech startup?

A reported reduction of around 350 employees is material under almost any startup restructuring, and the estimated 30% to 35% proportion makes the change especially consequential. The percentage indicates that Even Healthcare is not merely removing a small management layer or pausing hiring but substantially altering the size and composition of its organisation.

External workforce datasets illustrate how quickly the organisation had expanded beforehand, although such estimates should not be treated as official headcount disclosures. Revelio Labs estimated Even Healthcare had approximately 1,078 employees as of March 2026 and recorded significant workforce growth over preceding years. LinkedIn’s company profile, by comparison, displays a smaller number of identifiable platform members and classifies the business within its own employee-size range, highlighting why third-party employee counts can vary depending on methodology.

The reported layoff percentage supplied by sources familiar with the company is therefore more useful than attempting to derive a precise remaining headcount from public platforms. What can be said with greater confidence is that a reduction approaching one-third of the workforce represents a significant reset after a period of rapid organisational expansion.

This pattern is increasingly visible across venture-backed businesses that grew teams around one commercial model before discovering that the next stage of scaling requires a different cost structure. The challenge is ensuring that workforce reductions remove duplication and lower overhead without eliminating institutional knowledge or operational capacity required for the new strategy.

Can Even Healthcare’s hospital model justify both fresh investment and major job cuts?

The answer will ultimately depend on the economics of the hospitals rather than the size of the funding round. If Even Healthcare can reproduce the early performance it has reported from its first Bengaluru facility, expand utilisation and manage patients across primary care, hospitalisation and recovery more efficiently than fragmented healthcare models, then reallocating capital toward hospitals may eventually produce a stronger business.

Fresh financing gives the company additional room to test that proposition. The ₹208.24 crore Series B approval led by Khosla Ventures also signals that major existing investors are prepared to commit more capital at a stage when Even Healthcare’s reported accounting losses remain substantial.

Yet funding itself is not validation of sustainable economics. New equity can finance hospital openings and absorb operating losses, but long-term value creation requires individual facilities and the wider membership ecosystem to generate attractive returns on the capital deployed. The reported layoffs suggest management recognises that expansion cannot be funded simply by allowing the existing corporate cost base to grow alongside physical infrastructure.

For Even Healthcare, the strategic bet is becoming increasingly clear. The company appears willing to operate with a materially leaner organisation while committing more capital to owning and controlling parts of the healthcare-delivery chain. That could make the business more vertically integrated and potentially more defensible, but it also transfers more operational risk directly onto the company.

The next evidence investors will need is therefore not another fundraising headline. It will be whether new hospitals can achieve utilisation and break-even performance comparable with the company’s claims for its first facility, whether the wider business can narrow its losses as revenue increases and whether the restructuring produces a genuinely more efficient organisation rather than simply a smaller one.

For employees, the immediate consequence is much less abstract. Approximately 350 positions have reportedly been eliminated across multiple teams as a business that expanded rapidly around one model reorganises itself around another. For Even Healthcare and its investors, the eventual verdict will depend on whether concentrating money and personnel behind hospitals can turn rapid healthcare expansion into sustainable economics.